VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
-5.68%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.44B
AUM Growth
+$1.44B
(+66%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-1.02%
Top 10 Holdings %
Top 10 Hldgs %
79.03%
Holding
50
New
2
Increased
3
Reduced
3
Closed
2
Top Buys
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$9.23M |
| 2 |
Arcellx
ACLX
|
$8.96M |
| 3 |
Zai Lab
ZLAB
|
$2.59M |
| 4 |
Fulcrum Therapeutics
FULC
|
$1.57M |
| 5 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$935K |
Top Sells
| 1 |
Ventyx Biosciences
VTYX
|
$23.5M |
| 2 |
Vera Therapeutics
VERA
|
$7.75M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$5.18M |
| 4 |
Merus
MRUS
|
$1.56M |
| 5 |
Compass Therapeutics
CMPX
|
$5.26K |
Sector Composition
| 1 | Healthcare | 99.27% |
| 2 | Materials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVA
1
DELISTED
Sinovac Biotech, Ltd
SVA
| $615M | 42.7% | 5,900,000 | – | – |
|
|
GTH
2
DELISTED
Genetron Holdings Limited ADS
GTH
| $105M | 7.26% | 8,124,174 | – | – |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $85.3M | 5.92% | 4,249,918 | – | – |
|
4
Harmony Biosciences
HRMY
$2.12B
| $85.1M | 5.9% | 2,606,247 | – | – |
|
5
Terns Pharmaceuticals
TERN
$609M
| $78.8M | 5.47% | 6,657,992 | – | – |
|
6
Viridian Therapeutics
VRDN
$1.5B
| $42.7M | 2.96% | 1,678,207 | – | – |
|
7
Geron
GERN
$893M
| $41.8M | 2.9% | 19,282,834 | – | – |
|
|
AVDL
8
Avadel Pharmaceuticals
AVDL
$1.43B
| $34.5M | 2.39% | 3,761,438 +1,007,343 | +37% | +$9.23M |
|
9
Tarsus Pharmaceuticals
TARS
$2.47B
| $28.4M | 1.97% | 2,262,200 | – | – |
|
10
Astria Therapeutics
ATXS
$349M
| $22.4M | 1.55% | 1,681,199 | – | – |
|
11
Vaxcyte
PCVX
$4B
| $21.7M | 1.51% | 579,508 | – | – |
|
12
Cogent Biosciences
COGT
$1.69B
| $21.5M | 1.49% | 1,994,941 | – | – |
|
|
KDNY
13
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $20.2M | 1.4% | 872,151 | – | – |
|
|
14
Ventyx Biosciences
VTYX
$171M
| $20.2M | 1.4% | 602,075 -701,219 | -54% | -$23.5M |
|
|
VECT
15
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $19.9M | 1.38% | 2,333,300 | – | – |
|
16
ALX Oncology
ALXO
$62.7M
| $19.1M | 1.32% | 4,220,048 | – | – |
|
|
ALLK
17
DELISTED
Allakos
ALLK
| $18.3M | 1.27% | 4,120,134 | – | – |
|
|
18
Zai Lab
ZLAB
$3.68B
| $13.9M | 0.96% | 416,640 +77,919 | +23% | +$2.59M |
|
19
Legend Biotech
LEGN
$6.41B
| $11.8M | 0.82% | 244,375 | – | – |
|
|
20
Compass Therapeutics
CMPX
$483M
| $11.6M | 0.81% | 3,556,023 -1,607 | -0% | -$5.26K |
|
|
AMRS
21
DELISTED
Amyris Inc.
AMRS
| $10.5M | 0.73% | 7,750,828 | – | – |
|
|
22
Arcellx
ACLX
$3.85B
| $8.96M | 0.62% | +290,713 | New | +$8.96M |
|
23
Instil Bio
TIL
$182M
| $8.25M | 0.57% | 12,486,787 | – | – |
|
|
BLU
24
DELISTED
BELLUS Health Inc.
BLU
| $7.32M | 0.51% | 1,017,152 | – | – |
|
25
Aclaris Therapeutics
ACRS
$209M
| $7.27M | 0.5% | 898,631 | – | – |
|